US2004120944A1PendingUtilityA1
Antibody-containing blend obtained from eggs
Priority: Apr 8, 1998Filed: Mar 10, 2003Published: Jun 24, 2004
Est. expiryApr 8, 2018(expired)· nominal 20-yr term from priority
C07K 2317/11A61K 2039/505C07K 16/26A61K 35/57
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to blending eggs from lots produced over the course of the egg laying cycle of immunized avians, to form an antibody-containing blend containing both early-stage antibodies and late-stage antibodies. The administration of an effective amount of such an antibody-containing blend to a subject increases the efficacy of the antibody blend its ability to bind antigen over that of a substance containing the same amount of antibody obtained from eggs containing either early-stage antibodies or late-stage antibodies only.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for increasing efficacy of an antibody in a subject comprising:
A. inducing an immune response in an egg-producing animal with at least one immunogen; B. collecting eggs from the egg-producing animal for a predetermined period of time following induction of said immune response; C. processing all of the collected eggs together to form a blended mix; and D. administering to the subject a portion of the blended mix which contains an effective titer of said antibody.
2 . The method of claim 1 wherein the predetermined period of time comprises at least 30 weeks.
3 . The method of claim 2 wherein the predetermined period of time comprises 30 to 60 weeks.
4 . The method of claim 1 wherein the immunogen is selected from the group consisting of proteins, enzymes, bacteria, viruses, protozoa, fungi, cellular antigens, allergens and combinations thereof.
5 . The method of claim 4 wherein the immunogen comprises cholecystokinin.
6 . The method of claim 1 wherein the egg-producing animal comprises an avian.
7 . The method of claim 6 wherein the avian is selected from the group consisting of fowls, turkeys, ducks and geese.
8 . An antibody-containing substance comprising an effective titer of at least one antibody, said antibody comprising all antibody structures produced within an animal over a predetermined period of time following induction of an immune response in said animal.
9 . The antibody-containing substance of claim 8 wherein the animal comprises an egg-producing animal.
10 . The antibody-containing substance of claim 9 further comprising an egg product.
11 . The antibody-containing substance of claim 10 wherein the egg product comprises an effective amount of egg obtained from a blended mix of all eggs produced by one or more egg-producing animal for at least 30 weeks following induction of the immune response.
12 . An antibody-containing substance comprising an effective titer of at least one antibody, said antibody-containing substance comprising an egg product obtained from a blended mix of all eggs produced over a predetermined period of time by one or more egg-producing animals which have been immunized with at least one immunogen.
13 . The antibody-containing substance of claim 12 wherein the predetermined period of time comprises at least 30 weeks.
14 . The antibody-containing substance of claim 13 wherein the predetermined period of time comprises 30 to 60 weeks.
15 . The antibody-containing substance of claim 12 wherein the immunogen comprises an antigen selected from the group consisting of proteins, enzymes, bacteria, viruses, protozoa, fungi, cellular antigens, allergens and combinations thereof.
16 . The antibody-containing substance of claim 15 wherein the immunogen comprises cholecystokinin.
17 . The antibody-containing substance of claim 12 wherein the egg-producing animal comprises an avian.
18 . The antibody-containing substance of claim 17 wherein the avian is selected from the group consisting of fowls, turkeys, ducks and geese.Join the waitlist — get patent alerts
Track US2004120944A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.